Vericel Corp
VCEL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000887359
In the last 90 days, Vericel Corp insiders filed 0 open-market purchases and 3 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $2.47B in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Vericel Corp as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 185
- −16 vs. Q3 2021
- Shares held
- 52.0M
- +1.29M (+2.5%) vs. Q3 2021
- Total value
- $2.04B
- −$434.1M (−17.5%) vs. Q3 2021
- New holders
- 19
- 66 more added
- Sold out
- 35
- 71 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VCEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 320 | $2.47B |
| Q1 2026 | 280 | $1.78B |
| Q4 2025 | 274 | $1.93B |
| Q3 2025 | 249 | $1.67B |
| Q2 2025 | 273 | $2.35B |
| Q1 2025 | 277 | $2.39B |
| Q4 2024 | 278 | $2.87B |
| Q3 2024 | 268 | $2.15B |
| Q2 2024 | 261 | $2.32B |
| Q1 2024 | 257 | $2.68B |
| Q4 2023 | 227 | $1.84B |
| Q3 2023 | 214 | $1.73B |
| Q2 2023 | 202 | $1.88B |
| Q1 2023 | 200 | $1.48B |
| Q4 2022 | 178 | $1.32B |
| Q3 2022 | 180 | $1.21B |
| Q2 2022 | 183 | $1.34B |
| Q1 2022 | 197 | $2.01B |
| Q4 2021 | 185 | $2.04B |
| Q3 2021 | 202 | $2.48B |
| Q2 2021 | 205 | $2.57B |
| Q1 2021 | 205 | $2.75B |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Vericel Corp; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bamco Inc | 0 | $0 | 0.00% | −12,865−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −12,483−100.0% | Sold out |
| Bellwether Advisors, LLC | 0 | $0 | 0.00% | −11,498−100.0% | Sold out |
| V Wealth Advisors LLC | 0 | $0 | 0.00% | −10,957−100.0% | Sold out |
| Stephens Inc | 0 | $0 | 0.00% | −10,779−100.0% | Sold out |
| Crossmark Global Holdings, Inc. | 0 | $0 | 0.00% | −9,800−100.0% | Sold out |
| Cordant, Inc. | 0 | $0 | 0.00% | −8,500−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −5,904−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −4,955−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −4,931−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −4,510−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −4,400−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −3,320−100.0% | Sold out |
| Capital Advisory Group Advisory Services, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −235−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −155−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −159−100.0% | Sold out |
| First Horizon Advisors, Inc. | 0 | $0 | 0.00% | −82−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −71−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −61−100.0% | Sold out |
| Berman Capital Advisors, LLC | – | – | – | – | Not filed |